S.I. No. 251/1987 - Misuse of Drugs Act, 1977 (Controlled Drugs) (Declaration) Order, 1987.

1. The following substances and products, namely:—

(

a

) Alfentanil; Carfentanil; Cathinone; Eticyclidine; Lofentanil; Nabilone; Phencyclidine; Rolicyclidine; Sufentanil; Tenocyclidine; Tilidine; N-(1-Benzyl—4—piperidyl) propionanilide;

1—Phenylcyclohexylamine;

4—(1—Phenylcyclohexyl) morpholine;

1—Piperidinocyclohexanecarbonitrile;

N—[1—(2—Thenyl]—4—piperidyl] propionanilide;

4—[1—(2—Thienyl] cyclohexyl] morpholine;

1—[1—(2—Thienyl] cyclohexyl pyrrolidine.

(

b

) any substance (not being a substance otherwise specified in this Schedule or in the Schedule to the Act) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(

c

) any substance (not being methoxyphenamine or a substance otherwise specified in this Schedule or in the Schedule to the Act) structurally derived from phenethylamine, an N-alkyl—phenethylamine,

a

—methylphenethylamine, an N—alkyl—

a

—methylphenethylamine,

a

—ethylphenethylamine, or an N—alkyl—

a

—ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents;

(

d

) any substance (not being a substance otherwise specified in this Schedule or in the Schedule to the Act) structurally derived from fentanyl by modification in one or more of the following ways, that is to say,

(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi) by replacement of the N-propionyl group by another acyl group;

(

e

) any substance (not being a substance otherwise specified in this Schedule or in the Schedule to the Act) structurally derived from pethidine by modification in one or more of the following ways, that is to say,

(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v) by formation of an N-oxide or of a quaternary base;

(

f

) any ester or ether of a substance specified in this paragraph, not being a substance otherwise specified in this Schedule or in the Schedule to the Act.

2. The following substances, namely:—

(

a

) Alprazolam; Bromazepam; Butorphanol; Camazepam; Cathine; Chlordiazepoxide; Clobazam; Clonazepam; Clorazepic Acid; Clotiazepam; Cloxazolam; Delorazepam; Dextropropoxyphene; Diazepam; Diethylpropion; Estazolam; Ethchlorvnol; Ethinamate; Ethyl loflazepate; Fencamfamin; Fenethylline; Fenproporex; Fludiazepam; Flunitrazepam; Flurazepam; Glutethimide; Halazepam; Haloxazolam; Ketazolam; Lefetamine; Loprazolam; Lorazepam; Lormetazepam; Mazindol; Mecloqualone; Medazepam; Mefenorex; Meprobamate; Methyprylone; Nalbuphine; Nimetazepam; Nitrazepam; Nordazepam; Oxazepam; Oxazolam; Pemoline; Pentazocine; Phentermine; Pinazepam; Prazepam; Propylhexedrine; Pyrovalerone; Selegiline; Temazepam; Tetrazepam; Triazolam; N—Ethylamphetamine; Phenylacetone.

(

b

) any substance (not being a substance otherwise specified in this Schedule or in the Schedule to the Act) structurally derived from barbituric acid by disubstitution at the 5,5 positions, whether or not there is also substitution at the 1 position by a methyl substituent.

3. Any stereoisomeric form of a substance specified in paragraph 1 or 2 above not being phenylpropanolamine.

4. Any salt of a substance specified in paragraphs 1 to 3 above.

5. Any preparation or other product containing any proportion of a substance or product specified in any of paragraph 1 to 4 above.

GIVEN under the Official Seal of the Government, this 29th Day of September, 1987.

CHARLES J. HAUGHEY,

Taoiseach.

EXPLANATORY NOTE

The purpose of this Order is to declare certain substances, products and preparations to be controlled drugs for the purposes of the

Misuse of Drugs Act, 1977

.

S.I. No. 251 of 1987.

MISUSE OF DRUGS ACT, 1977 (CONTROLLED DRUGS) (DECLARATION) ORDER, 1987.

The Government, in exercise of the powers conferred on them by

Section 2

(2) of the

Misuse of Drugs Act, 1977

(No. 12 of 1977), hereby make the following Order:—